Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression

被引:0
作者
Xianbing Peng
Qun Zhang
Yi Zeng
Jin Li
Lixin Wang
Ping Ai
机构
[1] Hubei University of Medicine,Otorhinolaryngologieal Department, Renmin Hospital
[2] The Second Affiliated Hospital of Wenzhou Medical University,Otorhinolaryngologieal Department
来源
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词
Evodiamine; Nasopharyngeal carcinoma; Matrix metalloproteinase-2; Migration; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1173 / 1184
页数:11
相关论文
共 297 条
  • [1] Pan Y(2013)Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways Oncogene 32 2756-2766
  • [2] Zhang Q(2012)A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma Ann Oncol 23 997-1005
  • [3] Atsaves V(2012)Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches Semin Cancer Biol 22 79-86
  • [4] Yang H(2012)Targeting Jab1/CSN5 in nasopharyngeal carcinoma Cancer Lett 326 155-160
  • [5] Claret FX(2007)Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments Expert Rev Mol Med 9 1-24
  • [6] Chia WK(2008)Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions Cancer Sci 99 1311-1318
  • [7] Wang WW(2011)Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 212-236
  • [8] Teo M(2012)Inhibitory effect of Trolox on the migration and invasion of human lung and cervical cancer cells Int J Mol Med 29 245-251
  • [9] Tai WM(2000)Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis Eur J Cancer 36 1621-1630
  • [10] Lim WT(2005)Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells Eur J Pharm Sci 25 57-65